{"id":"https://openalex.org/W4361262402","doi":"https://doi.org/10.1158/0008-5472.c.6495785.v1","title":"Data from A Dual Phosphoinositide-3-Kinase \u03b1/mTOR Inhibitor Cooperates with Blockade of Epidermal Growth Factor Receptor in PTEN-Mutant Glioma","display_name":"Data from A Dual Phosphoinositide-3-Kinase \u03b1/mTOR Inhibitor Cooperates with Blockade of Epidermal Growth Factor Receptor in PTEN-Mutant Glioma","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361262402","doi":"https://doi.org/10.1158/0008-5472.c.6495785.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6495785.v1","doi":"https://doi.org/10.1158/0008-5472.c.6495785.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6495785.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6495785.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102276889","display_name":"Qi-Wen Fan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi-Wen Fan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Christine K. Cheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine K. Cheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090555697","display_name":"Theodore P. Nicolaides","orcid":"https://orcid.org/0000-0002-0637-1086","observed_orcids":["https://orcid.org/0000-0002-0637-1086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Theodore P. Nicolaides","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037267842","display_name":"Christopher S. Hackett","orcid":"https://orcid.org/0000-0003-4692-2433","observed_orcids":["https://orcid.org/0000-0003-4692-2433"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher S. Hackett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016747773","display_name":"Zachary A. Knight","orcid":"https://orcid.org/0000-0001-7621-1478","observed_orcids":["https://orcid.org/0000-0001-7621-1478"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zachary A. Knight","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079376363","display_name":"Kevan M. Shokat","orcid":"https://orcid.org/0000-0001-8590-7741","observed_orcids":["https://orcid.org/0000-0001-8590-7741"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevan M. Shokat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5073603294","display_name":"William A. Weiss","orcid":"https://orcid.org/0000-0003-2230-9132","observed_orcids":["https://orcid.org/0000-0003-2230-9132"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William A. Weiss","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.06669999659061432,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi-103","display_name":"PI-103","score":0.9990000128746033},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/pi3kalpha-inhibition","display_name":"PI3K\u03b1 inhibition","score":0.6830000281333923},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.9409999847412109},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.8500000238418579},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.4779999852180481}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.9145368337631226},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.9047403335571289},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7665396928787231},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5947077870368958},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5922380685806274},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.49839162826538086},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.415425181388855},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3355728089809418},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32368505001068115},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29117077589035034},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25811833143234253},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.2472737431526184},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20226773619651794},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0741715133190155}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6495785.v1","doi":"https://doi.org/10.1158/0008-5472.c.6495785.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6495785.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6495785.v1","doi":"https://doi.org/10.1158/0008-5472.c.6495785.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6495785.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2159566901","https://openalex.org/W4361266099","https://openalex.org/W2125887187","https://openalex.org/W2109467838","https://openalex.org/W2036246927","https://openalex.org/W2050858145","https://openalex.org/W2110523823","https://openalex.org/W2132344640","https://openalex.org/W2972038352","https://openalex.org/W2135529788"],"abstract_inverted_index":{"Abstract":[0],"We":[1],"have":[2],"shown":[3],"previously":[4],"that":[5,92,123],"blockade":[6],"of":[7,18,46,75,84,112,118,127,134,150],"epidermal":[8],"growth":[9],"factor":[10],"receptor":[11],"(EGFR)":[12],"cooperates":[13],"with":[14,36,107],"a":[15,42,124,138],"pan-selective":[16],"inhibitor":[17,39,45,111,117,126],"phosphoinositide-3-kinase":[19],"(PI3K)":[20],"in":[21,32,55,66,77,89,147],"EGFR-driven":[22,29],"glioma.":[23,153],"In":[24],"this":[25,78],"communication,":[26],"we":[27,87],"tested":[28],"glioma":[30,91],"differing":[31],"PTEN":[33],"status,":[34],"treating":[35],"the":[37,72,82,132,148],"EGFR":[38,135],"erlotinib":[40,61,76,96,106],"and":[41,48,95,129,145],"novel":[43],"dual":[44,125],"PI3K\u03b1":[47,128],"mTOR":[49,130,146],"(PI-103).":[50],"Erlotinib":[51],"blocked":[52],"proliferation":[53],"only":[54],"PTENwt":[56],"cells":[57],"expressing":[58],"EGFR.":[59],"Although":[60],"monotherapy":[62,101],"showed":[63,88],"little":[64],"effect":[65],"PTENmt":[67,90],"glioma,":[68],"PI-103":[69,94],"greatly":[70],"augmented":[71],"antiproliferative":[73],"efficacy":[74],"setting.":[79],"To":[80],"address":[81],"importance":[83],"PI3K":[85],"blockade,":[86,136],"combining":[93,105],"was":[97],"superior":[98],"to":[99,103],"either":[100,108],"or":[102,114],"therapy":[104],"rapamycin":[109],"(an":[110,116],"mTOR)":[113],"PIK-90":[115],"PI3K\u03b1).":[119],"These":[120],"experiments":[121],"show":[122],"augments":[131],"activity":[133],"offering":[137],"mechanistic":[139],"rationale":[140],"for":[141],"targeting":[142],"EGFR,":[143],"PI3K\u03b1,":[144],"treatment":[149],"EGFR-driven,":[151],"PTEN-mutant":[152],"[Cancer":[154],"Res":[155],"2007;67(17):7960\u20135]":[156]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-03-31T00:00:00"}